Letter

Switching prescription drugs to over the counter: Willingness to buy statin over the counter is not related to risk of heart disease

BMJ 2005; 330 doi: 10.1136/bmj.330.7496.905-a (Published 14 April 2005)
Cite this as: BMJ 2005;330:905.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Jerry Quill (jdquill@yahoo.com), fourth year medical student, University of Bristol,
  2. Richard Martin (Richard.Martin@bristol.ac.uk), senior lecturer in epidemiology and public health
  1. Department of Social Medicine, University of Bristol, Bristol BS8 2PR

    EDITOR—Appropriate self treatment is an important aspect of both the European and American healthcare systems.1 In August 2004 simvastatin 10 mg (Zocor Heart-Pro) became the first statin approved for over the counter sale by pharmacists for people at “moderate” risk of a major coronary event.2 Is this is another ill conceived example of “creeping privatisation” or a reasonable attempt to empower …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular